Latest It Services News

AMP Limited reports a strong second quarter with Platforms net cashflows soaring 63.2% and Superannuation & Investments achieving positive net cashflows for the first time since 2017. AMP Bank remains steady amid ongoing innovation and market volatility.

South32 has exceeded its FY25 production targets, driven by a 20% increase in copper output and significant progress at its Hermosa project, while streamlining its portfolio through key divestments.

Centrepoint Alliance has reported a robust FY25 with EBITDA rising 16% and net profit before tax jumping 30%, driven by strong adviser growth and strategic platform launches.

Equity Story Group has secured a transformative acquisition of Baker Young Limited, marking its entry into full-service wealth management and a major boost to its national footprint and recurring revenue.

Perenti Limited has reported a substantial beat on its FY25 free cash flow, reaching approximately A$280 million, well above its prior guidance of A$150 million, driven by asset sales and operational efficiencies.

Australian Unity Limited has agreed to acquire Plena Healthcare for $70 million, significantly scaling its Home Health services and workforce. The move aims to create one of Australia's leading integrated healthcare providers, pending regulatory approval.

Euroz Hartleys Group Limited has secured shareholder approval for a $63 million capital return, marking a significant milestone in its long history of shareholder distributions.

Yugo Metals Limited has launched a $100,000 capital raising through a new options offer, aiming to bolster working capital while navigating significant geopolitical and operational challenges in Bosnia and Herzegovina.

Pentanet Limited has secured a $2 million finance facility to fund the final payment for its 5G spectrum licence, reinforcing its growth strategy in telecommunications and cloud gaming.

Connexion Mobility reported steady revenue growth and a 7% increase in net profit before tax for Q4 FY25, driven by expanding SaaS subscriptions and strategic product enhancements.

TAL Dai-ichi Life Australia has obtained all necessary regulatory approvals, including from APRA, to finalize its minority investment in Challenger Limited, acquiring a 19.9% equity stake.

Mesoblast has reported a strong commercial debut for Ryoncil, the first FDA-approved mesenchymal stromal cell therapy for pediatric steroid-refractory acute graft-versus-host disease, generating US$13.2 million in gross revenue in its initial quarter. The company is advancing regulatory and clinical milestones while expanding insurance coverage across the US.